poly(methyl vinyl ether-co-maleic anhydride)

Also Known As:

Gantrez AN 119; MEMAC; PAM14 polymer; PMVE-MA; PVM-MA copolymer; methoxyethylene-maleic anhydride copolymer; methyl vinyl ether-maleic acid copolymer; methyl vinyl ether-maleic anhydride copolymer; methylvinylether-maleic acid copolymer; polymethylvinylether-co-maleic anhydride; polyvinylmethyl ether-maleic acid copolymer; 2,5-Furandione, polymer with methoxyethene

Networked: 35 relevant articles (16 outcomes, 12 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	DeVizio, William: 10 articles (03/2013 - 02/2002)
2.	Stewart, Bernal: 7 articles (09/2015 - 01/2008)
3.	Proskin, Howard M: 6 articles (07/2011 - 01/2008)
4.	Mateo, Luis R: 4 articles (09/2015 - 03/2013)
5.	Azevedo, Ricardo Bentes: 3 articles (01/2018 - 12/2015)
6.	Mosiniewicz-Szablewska, Ewa: 3 articles (01/2018 - 12/2015)
7.	Muehlmann, Luis Alexandre: 3 articles (01/2018 - 12/2015)
8.	Suchocki, Piotr: 3 articles (01/2018 - 12/2015)
9.	Mello, Sarita: 3 articles (03/2013 - 07/2011)
10.	Chaknis, Patricia: 3 articles (07/2011 - 01/2010)

Related Diseases

1.	Gingivitis 01/01/1993 - "A review of plaque, gingivitis, calculus and caries clinical efficacy studies with a dentifrice containing triclosan and PVM/MA Copolymer." 01/01/1996 - "A review of plaque, gingivitis, calculus and caries clinical efficacy studies with a fluoride dentifrice containing triclosan and PVM/MA copolymer." 02/01/2002 - "However, liquid varieties recently have become available The authors conducted a study to determine whether a fluoridated liquid product with added triclosan and a polyvinyl methyl ether/maleic acid, or PVM/MA, copolymer delivery system is efficacious for the control of supragingival plaque and gingivitis. " 02/01/2002 - "Subjects who qualified with a suitable amount of existing plaque and gingivitis were given one of two dentifrices: an "experimental" liquid dentifrice containing 0.3 percent triclosan, 2.0 percent PVM/MA copolymer and 0.243 percent sodium fluoride, or NaF, in a silica base; or a "placebo" dentifrice containing 0.243 percent NaF in a silica base. " 11/01/1997 - "A total of one hundred fifty three healthy male and female adults were entered into a six month, double-blind clinical study designed to evaluate the effect of a dentifrice containing 0.3% triclosan and 2.0% PVM/MA copolymer in a 0.243% sodium fluoride/silica base, relative to a 0.243% sodium fluoride silica base control dentifrice on supragingival plaque accumulation and gingivitis. "
2.	Dentin Sensitivity 03/01/2013 - "The objective of this eight week, single-center, two-cell, double-blind, and randomized clinical study was to evaluate the dentin hypersensitivity reduction efficacy of a mouthwash using Pro-Argin™ Mouthwash Technology containing 0.8% arginine, PVM/MA copolymer, pyrophosphates, and 0.05% sodium fluoride in an alcohol-free base ("Arginine Mouthwash") compared to an ordinary mouthwash without any active ingredients ("Negative Control"). " 03/01/2013 - "Efficacy of a mouthwash containing 0.8% arginine, PVM/MA copolymer, pyrophosphates, and 0.05% sodium fluoride compared to a negative control mouthwash on dentin hypersensitivity reduction. " 03/01/2013 - "Efficacy of a mouthwash containing 0.8% arginine, PVM/MA copolymer, pyrophosphates, and 0.05% sodium fluoride compared to a commercial mouthwash containing 2.4% potassium nitrate and 0.022% sodium fluoride and a control mouthwash containing 0.05% sodium fluoride on dentine hypersensitivity: a six-week randomized clinical study." 04/01/2011 - "To study the effectiveness of a dentifrice containing polymethyl vinyl ether-maleic acid (PVM/MA) copolymer in a silica base in occluding dentin tubules for treatment of dentin sensitivity. " 03/01/2013 - "Efficacy in reducing dentine hypersensitivity of a regimen using a toothpaste containing 8% arginine and calcium carbonate, a mouthwash containing 0.8% arginine, pyrophosphate and PVM/MA copolymer and a toothbrush compared to potassium and negative control regimens: an eight-week randomized clinical trial."
3.	Hypersensitivity (Allergy) 07/01/2011 - "Anti-hypersensitivity mechanism of action for a dentifrice containing 0.3% triclosan, 2.0% PVM/MA copolymer, 0.243% NaF and specially-designed silica." 01/01/1994 - "Efficacy of a dentifrice containing potassium nitrate, soluble pyrophosphate, PVM/MA copolymer, and sodium fluoride on dentinal hypersensitivity: a twelve-week clinical study." 01/01/1994 - "It was concluded from this study that a dentifrice containing 5.0% potassium nitrate, 1.3% soluble pyrophosphate, 1.5% PVM/MA copolymer, and 0.243% sodium fluoride in a silica base is a clinically effective treatment for reducing dentinal hypersensitivity." 01/01/1994 - "The effect on dentinal hypersensitivity from the use of a dentifrice containing 5.0% potassium nitrate, 1.3% soluble pyrophosphate, 1.5% PVM/MA copolymer, and 0.243% sodium fluoride in a silica base over a twelve-week period was compared to a matching placebo dentifrice without potassium nitrate. " 01/01/1994 - "The Sensitive/Tartar Control dentifrice contains 5% potassium nitrate as the anti-hypersensitivity agent, 0.243% sodium fluoride as the anti-caries agent, 2% tetrasodium pyrophosphate and 1.5% polyvinylmethyl ether/maleic acid (PVM/MA) copolymer as the antitartar system. "
4.	Calculi (Calculus) 01/01/1993 - "A review of plaque, gingivitis, calculus and caries clinical efficacy studies with a dentifrice containing triclosan and PVM/MA Copolymer." 01/01/1994 - "The number of calculus-free sites, a second parameter of efficacy, also was compared and demonstrated an absolute difference of 32.6% in favor of the group using the dentifrice containing potassium nitrate, soluble pyrophosphate and PVM/MA copolymer compared to a placebo dentifrice (37.8% vs 5.2%, respectively). " 01/01/1996 - "A review of plaque, gingivitis, calculus and caries clinical efficacy studies with a fluoride dentifrice containing triclosan and PVM/MA copolymer." 01/01/2008 - "The overall results of this double-blind clinical study support the conclusion that after twelve weeks' use of a dentifrice containing 0.3% triclosan/2.0% PVM/MA copolymer/0.243% sodium fluoride in a 17% dual silica base provides significantly greater control of supragingival calculus formation relative to that of a commercially available dentifrice containing 0.243% sodium fluoride in a silica base." 01/01/1994 - "The dentifrice containing 5.0% potassium nitrate, 1.3% soluble pyrophosphate, 1.5% PVM/MA copolymer and 0.243% sodium fluoride in a silica base, inhibited supragingival calculus formation by 54.4%, as compared to a 0.243% sodium fluoride silica-based placebo dentifrice. "
5.	Dental Calculus 01/01/1998 - "The objective of this double-blind clinical study was to investigate the anticalculus efficacy of a new improved tartar control dentifrice formulation containing tetrasodium pyrophosphate, sodium tripolyphosphate, PVM/MA copolymer and 0.243% sodium fluoride in a silica base (New and Improved Colgate Tartar Control Fluoride Toothpaste with Micro-Cleaning Crystals) as the test dentifrice, compared to a previously marketed, American Dental Association-accepted, tartar control dentifrice formulation containing tetrasodium pyrophosphate, PVM/MA copolymer and 0.243% sodium fluoride in a silica base (Colgate Tartar Control Fluoride Toothpaste with Micro-Cleaning Crystals), as the positive control dentifrice. " 01/01/1994 - "A dentifrice containing 5% potassium nitrate, 1.3% soluble pyrophosphate, 1.5% polyvinylmethyl ether and maleic acid (PVM/MA) copolymer and 0.243% sodium fluoride in a silica base (Sensitive/Tartar Control) has been developed to concomitantly control tartar, caries and dentinal hypersensitivity. " 01/01/1994 - "The effect of a dentifrice containing 5.0% potassium nitrate, 1.3% soluble pyrophosphate, 1.5% PVM/MA copolymer, and 0.243% sodium fluoride in a silica base (Sensitive/Tartar Control) on dentinal hypersensitivity over a twelve-week period was compared to a commercially available dentifrice containing 5% potassium nitrate and 0.76% sodium monofluorophosphate in a dicalcium phosphate dihydrate base (Sensodyne-F). " 01/01/2008 - "The objective of this double-blind clinical study, conducted in harmony with Volpe-Manhold design for studies of dental calculus, was to compare the efficacy of a dentifrice containing 0.3% triclosan/2.0% polyvinylmethyl ether/maleic acid (PVM/MA) copolymer/0.243% sodium fluoride in a 17% dual silica base (Colgate Total Advanced Toothpaste) to that of a commercially available dentifrice containing 0.243% sodium fluoride in a silica base (Crest Cavity Protection Toothpaste) with respect to the reduction of supragingival calculus formation. "

Related Drugs and Biologics

1.	Sodium Fluoride (Ossin)
2.	Dentifrices (Dentifrice)
3.	Triclosan (pHisoHex)
4.	Silicon Dioxide (Silica)
5.	Toothpastes
6.	Lactic Acid (Lactate)
7.	Zinc
8.	Tin Fluorides (Floran)
9.	sodium polymetaphosphate (Calgon)
10.	potassium nitrate (saltpeter)

Related Therapies and Procedures

1.	Tooth Bleaching
2.	Drug Therapy (Chemotherapy)